Published in Support Care Cancer on September 29, 2015
The relationship of cognitive performance to concurrent symptoms, cancer- and cancer-treatment-related variables in women with early-stage breast cancer: a 2-year longitudinal study. J Cancer Res Clin Oncol (2016) 0.79
Management of Potential Long-Term Toxicities in Breast Cancer Patients. Curr Breast Cancer Rep (2016) 0.75
Modifiable and non-modifiable characteristics associated with sleep disturbance in oncology outpatients during chemotherapy. Support Care Cancer (2017) 0.75
Characteristics associated with inter-individual differences in the trajectories of self-reported attentional function in oncology outpatients receiving chemotherapy. Support Care Cancer (2016) 0.75
Cancer survivors' adherence to lifestyle behavior recommendations and associations with health-related quality of life: results from the American Cancer Society's SCS-II. J Clin Oncol (2008) 4.60
Neuroendocrine-immune mechanisms of behavioral comorbidities in patients with cancer. J Clin Oncol (2008) 3.30
Candidate mechanisms for chemotherapy-induced cognitive changes. Nat Rev Cancer (2007) 3.12
Cytokines and their relationship to the symptoms and outcome of cancer. Nat Rev Cancer (2008) 2.89
Longitudinal assessment of cognitive changes associated with adjuvant treatment for breast cancer: impact of age and cognitive reserve. J Clin Oncol (2010) 2.52
Perceived social isolation and cognition. Trends Cogn Sci (2009) 2.39
Meta-analysis of cognitive functioning in breast cancer survivors previously treated with standard-dose chemotherapy. J Clin Oncol (2012) 2.33
A scoring system for appraising mixed methods research, and concomitantly appraising qualitative, quantitative and mixed methods primary studies in Mixed Studies Reviews. Int J Nurs Stud (2009) 2.32
The relationship of APOE genotype to neuropsychological performance in long-term cancer survivors treated with standard dose chemotherapy. Psychooncology (2003) 2.00
Cancer- and cancer treatment-associated cognitive change: an update on the state of the science. J Clin Oncol (2012) 1.99
'Chemobrain' in breast carcinoma?: a prologue. Cancer (2004) 1.98
What is the effect of systemic anticancer treatment on cognitive function? Lancet Oncol (2004) 1.89
Updated evidence in support of diet and exercise interventions in cancer survivors. Acta Oncol (2010) 1.87
Confronting chemobrain: an in-depth look at survivors' reports of impact on work, social networks, and health care response. J Cancer Surviv (2009) 1.81
A metaanalysis of studies of the effects of cancer chemotherapy on various domains of cognitive function. Cancer (2005) 1.76
Promoting a healthy lifestyle among cancer survivors. Hematol Oncol Clin North Am (2008) 1.75
A review of the effects of physical activity and exercise on cognitive and brain functions in older adults. J Aging Res (2013) 1.58
Change in cognitive function after chemotherapy: a prospective longitudinal study in breast cancer patients. J Natl Cancer Inst (2006) 1.56
Alterations in brain activation during working memory processing associated with breast cancer and treatment: a prospective functional magnetic resonance imaging study. J Clin Oncol (2012) 1.49
Reduced hippocampal volume and verbal memory performance associated with interleukin-6 and tumor necrosis factor-alpha levels in chemotherapy-treated breast cancer survivors. Brain Behav Immun (2012) 1.48
Does tumor necrosis factor-alpha (TNF-α) play a role in post-chemotherapy cerebral dysfunction? Brain Behav Immun (2012) 1.40
Psychological experience of parents of children with type 1 diabetes: a systematic mixed-studies review. Diabetes Educ (2012) 1.38
Inflammation and cancer-related fatigue: mechanisms, contributing factors, and treatment implications. Brain Behav Immun (2012) 1.36
Neuropsychological sequelae of non-central nervous system cancer and cancer therapy. Neuropsychol Rev (2008) 1.35
An update on cancer- and chemotherapy-related cognitive dysfunction: current status. Semin Oncol (2011) 1.32
Subjective cognitive dysfunction in breast cancer patients: a systematic review. Psychooncology (2010) 1.32
Prevalence, mechanisms, and management of cancer-related cognitive impairment. Int Rev Psychiatry (2014) 1.30
Objective and subjective cognitive impairment following chemotherapy for cancer: a systematic review. Cancer Treat Rev (2012) 1.26
Chemotherapy-related cognitive dysfunction. Curr Neurol Neurosci Rep (2012) 1.23
A meta-analysis of the effects of chemotherapy on cognition in patients with cancer. Cancer Treat Rev (2012) 1.22
Chemotherapy-related cognitive impairment: the breast cancer experience. Oncol Nurs Forum (2012) 1.18
Cognitive function in breast cancer survivors. Cancer Treat Res (2009) 1.12
Cognitive function in postmenopausal women receiving adjuvant letrozole or tamoxifen for breast cancer in the BIG 1-98 randomized trial. Breast (2010) 1.09
Differential expression of cytokines in breast cancer patients receiving different chemotherapies: implications for cognitive impairment research. Support Care Cancer (2011) 1.07
Perceived stress and change in cognitive function among adults 65 years and older. Psychosom Med (2013) 1.06
Cognitive dysfunction and subjective complaints of cancer patients. a cross-sectional study in a cancer rehabilitation centre. Eur J Cancer (2004) 1.04
Cognitive impairment in older patients with breast cancer before systemic therapy: is there an interaction between cancer and comorbidity? J Clin Oncol (2014) 1.00
Alterations in brain structure and function in breast cancer survivors: effect of post-chemotherapy interval and relation to oxidative DNA damage. Breast Cancer Res Treat (2012) 0.97
Sleeping well with cancer: a systematic review of cognitive behavioral therapy for insomnia in cancer patients. Neuropsychiatr Dis Treat (2014) 0.96
No indications of cognitive side-effects in a prospective study of breast cancer patients receiving adjuvant chemotherapy. Psychooncology (2009) 0.96
The association between pro-inflammatory cytokines, regional cerebral metabolism, and cognitive complaints following adjuvant chemotherapy for breast cancer. Brain Imaging Behav (2013) 0.95
Predictors of cognitive decline after chemotherapy in breast cancer patients. J Int Neuropsychol Soc (2009) 0.95
Mechanisms of age-related cognitive change and targets for intervention: social interactions and stress. J Gerontol A Biol Sci Med Sci (2012) 0.94
Cognitive dysfunction among cancer survivors. Am J Phys Med Rehabil (2011) 0.92
Barriers to implementation of case management for patients with dementia: a systematic mixed studies review. Ann Fam Med (2014) 0.91
Cognitive functioning of postmenopausal breast cancer patients before adjuvant systemic therapy, and its association with medical and psychological factors. Crit Rev Oncol Hematol (2009) 0.91
Association of proinflammatory cytokines and chemotherapy-associated cognitive impairment in breast cancer patients: a multi-centered, prospective, cohort study. Ann Oncol (2015) 0.90
Two different sides of 'chemobrain': determinants and nondeterminants of self-perceived cognitive dysfunction in a prospective, randomized, multicenter study. Psychooncology (2010) 0.90
Cytokines as mediators of chemotherapy-associated cognitive changes: current evidence, limitations and directions for future research. PLoS One (2013) 0.89
Prospective longitudinal evaluation of a symptom cluster in breast cancer. J Pain Symptom Manage (2013) 0.88
Default mode network as a potential biomarker of chemotherapy-related brain injury. Neurobiol Aging (2014) 0.87
The influence of priming and pre-existing knowledge of chemotherapy-associated cognitive complaints on the reporting of such complaints in breast cancer patients. Psychooncology (2009) 0.86
Relationship between exercise behavior, cardiorespiratory fitness, and cognitive function in early breast cancer patients treated with doxorubicin-containing chemotherapy: a pilot study. Appl Physiol Nutr Metab (2013) 0.85
Neuroimaging, cancer, and cognition: state of the knowledge. Semin Oncol Nurs (2013) 0.85
Longitudinal assessment of cognitive changes associated with adjuvant treatment for breast cancer: the impact of APOE and smoking. Psychooncology (2014) 0.84
New approaches to understand cognitive changes associated with chemotherapy for non-central nervous system tumors. J Pain Symptom Manage (2013) 0.83
Effects of breast cancer treatment on the hormonal and cognitive consequences of acute stress. Psychooncology (2011) 0.83
Stress and inflammation: a biobehavioral approach for nursing research. West J Nurs Res (2010) 0.83
Brief self-report measure of work-related cognitive limitations in breast cancer survivors. J Cancer Surviv (2013) 0.83
Neuroimaging biomarkers and cognitive function in non-CNS cancer and its treatment: current status and recommendations for future research. Brain Imaging Behav (2013) 0.83
Hospital-based bereavement services following the death of a child: a mixed study review. Palliat Med (2014) 0.83
Cognitive changes in multiethnic Asian breast cancer patients: a focus group study. Ann Oncol (2012) 0.82
Potential factors associated with perceived cognitive impairment in breast cancer survivors. Support Care Cancer (2015) 0.82
Breast cancer and "chemobrain": the consequences of cognitive difficulties following chemotherapy and the potential for recovery. Mo Med (2009) 0.81
Stress, coping and cognitive deficits in women after surgery for breast cancer. J Clin Psychol Med Settings (2012) 0.81
Broadening the cancer and cognition landscape: the role of self-regulatory challenges. Psychooncology (2013) 0.81
Cognitive intervention for breast cancer patients undergoing adjuvant chemotherapy: a needs analysis. Cancer Nurs (2011) 0.80
Changes in perceived attentional function in women following breast cancer surgery. Breast Cancer Res Treat (2011) 0.80
Elevated prefrontal myo-inositol and choline following breast cancer chemotherapy. Brain Imaging Behav (2013) 0.80
Functional MRI studies in non-CNS cancers. Brain Imaging Behav (2013) 0.80
Women's experiences of cognitive changes or 'chemobrain' following treatment for breast cancer: a role for occupational therapy? Aust Occup Ther J (2014) 0.79
Perceived cognitive impairment in Chinese patients with breast cancer and its relationship with post-traumatic stress disorder symptoms and fatigue. Psychooncology (2014) 0.79
The effect of EEG biofeedback on reducing postcancer cognitive impairment. Integr Cancer Ther (2013) 0.78
Effects of chemotherapy and psychosocial distress on perceived cognitive disturbances in Asian breast cancer patients. Ann Pharmacother (2012) 0.78
Cognitive problems among breast cancer survivors: loneliness enhances risk. Psychooncology (2014) 0.77
Stress coping and changes in health behavior among cancer survivors: a report from the American Cancer Society's Study of Cancer Survivors-II (SCS-II). J Psychosoc Oncol (2013) 0.77